Sevelamer Carbonate Powder, For Suspension
Product Images NDC 69452-127

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69452-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Figure 2)

This chart depicts the percentage of patients achieving various reductions in serum phosphorus levels (mg/dL) from baseline, comparing Sevelamer Hydrochloride and an active control. The x-axis shows reduction in serum phosphorus, with a range from worsened increase to improved reduction, while the y-axis shows the percentage of patients with at least a given reduction. Both treatments show a similar trend in patient response.*

FDA Label Image

Figure 4: Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Figure 3)

Line graph showing phosphorus change from baseline over study weeks (0 to 52) comparing Sevelamer Hydrochloride and an Active-Control. The y-axis represents phosphorus change values from -5 to 2, with Sevelamer Hydrochloride depicted by solid black circles and Active-Control by red open squares. The graph indicates trends of phosphorus levels over time for two treatments.*

FDA Label Image

Image Description (Figure1)

A forest plot depicting subgroup analysis results for Sevelamer Carbonate versus placebo. The y-axis lists subgroups by screening BSA, baseline serum phosphorus, age, and dialysis status. The x-axis shows the least squares mean difference with 95% confidence intervals, indicating effects favoring Sevelamer Carbonate or placebo.*

FDA Label Image

Image1

Label for Sevelamer Carbonate 0.8 g powder for oral suspension, lemon flavor. The label includes the NDC 69452-126-60 and indicates prescription use only. The product is labeled by Bionpharma Inc.*

FDA Label Image

Image2

This image displays usage directions and storage instructions for Sevelamer Carbonate powder for suspension. It advises emptying the 0.8 g packet into at least 1 ounce of water, stirring, and drinking within 30 minutes. Storage is recommended at 15°C to 30°C with protection from moisture. The label also includes distributor information for Bionpharma Inc. and a barcode.*

FDA Label Image

Image3

Packaging label for Sevelamer Carbonate For Oral Suspension, 0.8 g packets, lemon flavor. This box contains 90 packets of powder for suspension, labeled for prescription use only. It features directions for use, storage instructions, and a list of inactive ingredients. The labeler is Bionpharma Inc., located in Princeton, NJ.*

FDA Label Image

Image4

Label for Sevelamer Carbonate oral suspension powder with a strength of 2.4 grams. The product is lemon flavored and marked as prescription only (Rx only). The label displays the NDC 69452-127-60 and the labeler is Bionpharma Inc.*

FDA Label Image

Image5

Text panel for Sevelamer Carbonate powder for suspension 2.4 g packet with directions for use instructing to mix the packet in at least 2 ounces of water, storage instructions between 15°C to 30°C, child safety warnings, and distributor information for Bionpharma Inc. located in Princeton, NJ. Includes a barcode and lot/expiration placeholder.*

FDA Label Image

Image6

Packaging label for Sevelamer Carbonate For Oral Suspension, 2.4 g packets, lemon flavor. The label indicates the product is a prescription drug, contains 90 packets per package, and is labeled by Bionpharma Inc. Directions and inactive ingredients are also listed, with storage instructions provided. The label includes a barcode and manufacturer address in Princeton, NJ.*

FDA Label Image

Figure 1: Structure Of Sevelamer Carbonate (Structure 1)

Chemical structure diagram of Sevelamer Carbonate, showing polymeric chains with ammonium groups (NH3+, NH2), bicarbonate ion (HCO3-), and additional amine and hydroxyl groups in the polymer structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.